To date, GSTp levels have been assessed in the bronchoalveolar fluid of systemic sclerosis patients, where they were found to be downregulated in individuals with lung fibrosis and were thought to play a protective role in the development of pulmonary fibrosis [33]. This evidence concerns the gene GSTP1 and pulmonary fibrosis.